EVOK icon

Evoke Pharma
EVOK

Overview Fund Trends Analyst Outlook Journalist POV

16 hedge funds and large institutions have $1.67M invested in Evoke Pharma in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

14% less capital invested

Capital invested by funds: $1.93M → $1.67M (-$262K)

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$12K
2
+$6.3K
3
+$5.64K
4
TRCT
Tower Research Capital (TRC)
New York
+$38
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$38

Top Sellers

1
-$17.2K
2
-$8.22K
3
-$6.63K
4
Wells Fargo
Wells Fargo
California
-$40
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$448K
2
$436K
3
$366K
4
$357K
5
$26.3K
6
$15.8K
7
$6.3K
8
$5.64K
9
$3.96K
10
$774
11
$586
12
$198
13
$110
14
$38
15
$37
16
–
17
–
18
–